%PDF-1.4 % 5 0 obj << /S /GoTo /D (abstract.1) >> endobj 8 0 obj (Abstract) endobj 9 0 obj << /S /GoTo /D (section.1) >> endobj 12 0 obj (Introduction) endobj 13 0 obj << /S /GoTo /D (section.2) >> endobj 16 0 obj (Materials and methods) endobj 17 0 obj << /S /GoTo /D (subsection.2.1) >> endobj 20 0 obj (Experimental design and diets) endobj 21 0 obj << /S /GoTo /D (subsection.2.2) >> endobj 24 0 obj (Performance trial of breeder quails) endobj 25 0 obj << /S /GoTo /D (subsection.2.3) >> endobj 28 0 obj (Immune assay) endobj 29 0 obj << /S /GoTo /D (subsubsection.2.3.1) >> endobj 32 0 obj (Egg yolk IgY purification) endobj 33 0 obj << /S /GoTo /D (subsubsection.2.3.2) >> endobj 36 0 obj (Cutaneous basophil hypersensitivity) endobj 37 0 obj << /S /GoTo /D (subsubsection.2.3.3) >> endobj 40 0 obj (Antibody titer to sheep red blood cells) endobj 41 0 obj << /S /GoTo /D (subsubsection.2.3.4) >> endobj 44 0 obj (White blood cell) endobj 45 0 obj << /S /GoTo /D (subsection.2.4) >> endobj 48 0 obj (Assay of antioxidant indices and plasma lipids) endobj 49 0 obj << /S /GoTo /D (subsection.2.5) >> endobj 52 0 obj (Statistical analysis) endobj 53 0 obj << /S /GoTo /D (section.3) >> endobj 56 0 obj (Results) endobj 57 0 obj << /S /GoTo /D (subsection.3.1) >> endobj 60 0 obj (Productive performance) endobj 61 0 obj << /S /GoTo /D (subsection.3.2) >> endobj 64 0 obj (Egg quality parameters) endobj 65 0 obj << /S /GoTo /D (subsection.3.3) >> endobj 68 0 obj (Fertility, hatchability and embryonic mortality) endobj 69 0 obj << /S /GoTo /D (subsection.3.4) >> endobj 72 0 obj (Immune assay) endobj 73 0 obj << /S /GoTo /D (subsubsection.3.4.1) >> endobj 76 0 obj (Immunoglobulins and IgY transfer to offspring) endobj 77 0 obj << /S /GoTo /D (subsubsection.3.4.2) >> endobj 80 0 obj (Humoral and cell mediate immune) endobj 81 0 obj << /S /GoTo /D (subsubsection.3.4.3) >> endobj 84 0 obj (White blood cells) endobj 85 0 obj << /S /GoTo /D (subsection.3.5) >> endobj 88 0 obj (Antioxidant enzyme activities and lipid peroxidation) endobj 89 0 obj << /S /GoTo /D (subsection.3.6) >> endobj 92 0 obj (Plasma lipids) endobj 93 0 obj << /S /GoTo /D (section.4) >> endobj 96 0 obj (Discussion) endobj 97 0 obj << /S /GoTo /D (section.5) >> endobj 100 0 obj (Conclusion) endobj 101 0 obj << /S /GoTo /D (dataavailability.1) >> endobj 104 0 obj (Data availability) endobj 105 0 obj << /S /GoTo /D (authorcontribution.1) >> endobj 108 0 obj (Author contributions) endobj 109 0 obj << /S /GoTo /D (competinginterests.1) >> endobj 112 0 obj (Competing interests) endobj 113 0 obj << /S /GoTo /D (acknowledgements.1) >> endobj 116 0 obj (Acknowledgements) endobj 117 0 obj << /S /GoTo /D (reviewstatement.1) >> endobj 120 0 obj (Review statement) endobj 121 0 obj << /S /GoTo /D (biblio.1) >> endobj 124 0 obj (References) endobj 125 0 obj << /S /GoTo /D [126 0 R /Fit ] >> endobj 131 0 obj << /Length 3946 /Filter /FlateDecode >> stream xZ[7~WΩ:;[ ؇OόC_&} _%w}m7Y?Ia#6 و@HwLl JxvGAMue{jl{ؚ;c*J7J%W/ֆUB8 v2<ép~ڠbGCGCcFŒv8EyUJm]d}K$T~R8)elJӭq1 x=?Tۆ.fmC-Q t pFz& hS~+(&%u Oo{??玄 bn@Vp3i̧|r@T ݥL$7TeA8؎&%V;]2pE&W)yyת6Vd UdQ,fynϟu?. L"*T8ԟV2w\6"臱@gy^$Լ7Y@%{}F&AG @8qITT6|tLmAχ֧QauXY4`AXvʌ8uj@#n`Wگ]#0Qt:\L*;[g߷%q;tkGqI7g>jKd"ŰXG %,mJC崳Xa`Xlw{I~m+KW4Y; ;k="/Bd!aX֜t7= [Xz%CqbCEm,"8t6: \M6)WB?70{o@,K`i,Gm:;p3.uA $,weo>cE[<⛱}"^C,5$41f!Jx{VÕ^7Hf_) sQF4Ayᅊw $%z!v#